Saturday, September 23, 2023
Saturday, September 23, 2023

Transforming Pharmacy with Paperless Prescriptions By Nadeem Sarwar, Founder & CEO at Phlo Connect

The expectation of seamless digital experiences has quickly become the norm across almost every domain of our society. However, unlike healthcare at large, workflows and procedures in pharmacies have changed very little over the last 300 years.

Hugely important processes, like issuing and collecting prescriptions, have (until very recently) been left untouched by digital innovation and technology.

The patient experience typically becomes fragmented and offline during the critical stage of prescribing and pharmacy, where one often sees a reversion to traditional, manual paper processes. These present a significant administrative burden, especially when a wet signature is still required on all paper prescriptions – and have meant that a true end-to-end digital health experience has remained elusive.

Patients often have to travel long distances in order to collect their prescriptions and medication, and clinicians become bogged down in paperwork. Critically, continued dependence on outdated prescribing practices results in a disconnect between the patient and the healthcare provider, coupled with delays, lost data, and significant inefficiencies.

Digital prescribing: a solution fit for the future

Digital prescribing was first rolled out in the NHS in 2013[1] and has proven to be both time and cost-effective, reducing the amount of paper processing required by GPs and pharmacists. It has, to date:

  • Saved the NHS an estimated £300 million between 2018-2021[2].
  • Saved GPs an average of 2 hours 33 minutes a day signing and producing electronic prescriptions versus paper ones1
  • Reduced time spent collecting and dispensing prescriptions by 1 hour 37 minutes for pharmacists1

However: despite success in the NHS, no universal digital prescribing system existed for private healthcare providers and telemedicine companies due, in part, to the existing legal framework for prescribing, which has presented challenges for digital solutions.

Until now.

At Phlo Connect, we are focused on delivering the benefits of digital prescribing and digital signing to healthcare teams and patients in the private sector.

This motivated the development of a signing tool fit for the future of medication dispensation and joined-up digital-first healthcare. Our new Advanced Digital Signing solution integrates easily with existing clinical systems and prescribing workflows, helping private healthcare providers digitise and streamline their pharmacy offerings. Ultimately, this gives patients wider, higher-quality choices for their healthcare needs.

Prescribing with Phlo Connect means that – for the first time in the private sector – prescribers will be able to easily offer digital prescriptions to patients and pharmacies, without the need for a hard copy, paper documentation, or a wet signature. Our solution allows clinicians to generate and ‘sign’ a digital prescription, and then send this to the Phlo digital pharmacy, which can deliver the medication to the patient’s door in a timeframe that suits them. This ultimately enables a trackable, digital prescribing journey from the point of prescription to delivery.

Time and effort are saved for prescribers, safety is improved, and patients get the medication they need without unnecessary delay: everyone benefits. Pharmacy and prescribing are one step closer to completing the modern makeover that the sector so urgently needs.

Editor’s Note: Nadeem Sarwar is the founder and CEO of Phlo Connect, the UK’s first and only on-demand digital pharmacy that offers real-time, secure prescription delivery across the UK, managing the logistics, pharmacy and technology to make it easier and more convenient for patients.



Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Experts Views and Opinions

The Hollywood Writers’ Strike and Ethical AI | By Ed Watal, Founder & Principal — Intellibus

Watal writes, "Less than 12 months ago, with the debut of AI-powered ChatGPT, the true power of AI hit the mainstream. Since then, it has established an unshakeable belief in everyone’s minds that artificial intelligence is here to stay and will forever alter a number of industries." What do you think? Read on.

Viraj Gandhi On Automation and Technology – to Drive Progress in Pharmaceutical Manufacturing

This article takes a closer look at the key benefits of automation and technology in pharmaceutical manufacturing and how Medivant Healthcare harnesses these solutions to drive progress across our production facilities. Read what Viraj Gandhi has to say.

Limb Loss and Preservation Registry (LLPR) Transforms Care Through Data and Insights | By Shawn Murphy, Vice President, Thought Leadership & Innovation Foundation...

Shawn Murphy writes, "The Limb Loss and Preservation Registry (LLPR) represents a pivotal development in patient care. It stands as the first collaborative database that unites hospital and health systems, provider organizations such as Accountable Care Organizations (ACOs), Integrated Delivery Networks (IDNs) and orthotic/prosthetic (O&P) practices, focusing on both upper and lower extremity acquired and congenital limb differences, as well as limb preservation populations. This collective effort has the potential to drive substantial advancements in patient outcomes, treatment effectiveness and care quality." Read to learn more.

It Takes an Ecosystem – Bringing Stakeholders Together is a Critical 1st Step to Solving Problems In Healthcare | By Andrew Cleeland, CEO, Fogarty...

Andrew Cleeland writes, "Introducing a new medical therapy or technology is a complex, expensive, and time-consuming journey, one that is fraught with significant risk. While innovation often starts with a clear, well-defined unmet clinical need, it must be paired with an equally compelling value proposition. My mentor, Dr. Thomas Fogarty, once said, “An idea, by itself, has no importance whatsoever; it is the implementation of that idea and its acceptance by others that brings benefit to our patients.” Read on.

Chemotherapy Starts With Scalp Cooling Treatment: The Path to Improved Access | By Claire Paxman, Director of Global Training of Paxman

Paxman writes, "When Real Housewives of Miami star Guerdy Abraira recently proclaimed “Chemo Starts Now” after shaving off her hair before starting her treatment for breast cancer in People Magazine1, this made me realize just how little the general public and even celebrities like Abraria know about the medical technology being utilized today, such as scalp cooling systems, to manage and prevent chemotherapy-induced hair loss." Read to learn more.

By using this website you agree to accept Medical Device News Magazine Privacy Policy